Published in FEBS Lett on November 01, 1976
Antibiotic induced electrophoretic mobility shifts of DNA restriction fragments. Nucleic Acids Res (1979) 0.92
Protection of (dA.dT) cluster regions in the DNAase I cleavage of DNA by specific interaction with netropsin. Nucleic Acids Res (1980) 0.82
Protection of particular cleavage sites of restriction endonucleases by distamycin A and actinomycin D. Nucleic Acids Res (1976) 1.47
Primary and secondary structure of rat 28 S ribosomal RNA. Nucleic Acids Res (1984) 1.44
Nucleotide sequence analysis of the spacer regions flanking the rat rRNA transcription unit and identification of repetitive elements. Nucleic Acids Res (1986) 1.39
Protection of particular endonuclease R. Hind III cleavage sites by distamycin A, propyl-distamycin and netropsin. Nucleic Acids Res (1977) 1.04
Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene (1999) 0.96
The energetics of the B-Z transition in DNA. J Biomol Struct Dyn (1987) 0.95
Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet (2001) 0.94
Structural organization of rat ribosomal genes restriction endonuclease analysis of genomic and cloned ribosomal DNAs. Gene (1982) 0.92
Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab (2000) 0.91
Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetol (2008) 0.90
Mapping of the major early endonuclease cleavage site of the rat precursor to rRNA within the internal transcribed spacer sequence of rDNA. Biochim Biophys Acta (1984) 0.89
The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel. Acta Diabetol (2011) 0.89
[Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1]. Mol Biol (Mosk) (2003) 0.87
Localization and structure of endonuclease cleavage sites involved in the processing of the rat 32S precursor to ribosomal RNA. Biochem J (1984) 0.85
Structural organization of rat ribosomal RNA genes: interspersed sequences and their putative role in the alignment of nucleosomes. Gene (1985) 0.85
Complex molecular structure of the gene coding for rat ceruloplasmin. Gene (1980) 0.84
A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab Res Rev (2004) 0.84
[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women]. Mol Biol (Mosk) (2006) 0.84
Regulation of restriction endonuclease activity with antibiotics. Adv Enzyme Regul (1978) 0.83
[Limitation of the action of restriction endonucleases by DNA-binding antibiotics]. Dokl Akad Nauk SSSR (1975) 0.83
[Integration of the genomes of the tick-borne encephalitis virus and of the cell in chronic infection due to this virus and SV40]. Dokl Akad Nauk SSSR (1981) 0.82
The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab (2006) 0.82
[Clinical and prognostic significance of genetic markers in craniocerebral injury (Part III)]. Zh Vopr Neirokhir Im N N Burdenko (2014) 0.81
Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study. Acta Diabetol (2003) 0.81
[Polymorphic markers TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population]. Genetika (2010) 0.81
The position of an essential tyrosine residue in the polypeptide chain of aspartate transaminase. FEBS Lett (1972) 0.81
Physical mapping of bacteriophage lambda DNA with restriction endonuclease HpaI. Gene (1978) 0.81
CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet (2001) 0.81
[Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors]. Mol Biol (Mosk) (2004) 0.80
[NOS3 gene polymorphism and left ventricular hypertrophy in patients with essential hypertension]. Kardiologiia (2002) 0.80
Nucleotide sequences in human chromosomal DNA from nonhepatic tissues homologous to the hepatitis B virus genome. Gene (1985) 0.80
[Alteration of SEMA3B gene expression levels in epithelial tumors]. Mol Biol (Mosk) (2009) 0.80
Distamycin A and its analogs as agents for blocking of endo R. EcoRI activity. Gene (1977) 0.80
Conformational changes of aspartate aminotransferases in the region of Cys-45 residue observed by means of spin label. Biochim Biophys Acta (1973) 0.80
[Association of GNB3 gene C825T polymorphism with coronary heart disease]. Genetika (2007) 0.79
Clinical significance of HIV DNA in polymorphonuclear neutrophils from patients with HIV infection. J Acquir Immune Defic Syndr (1993) 0.79
Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings. Neurosci Behav Physiol (2003) 0.79
Sequence heterogeneity in the internal transcribed spacers of two rat ribosomal DNA clones. Biochem Int (1984) 0.79
Carbohydrate components of aspartate transaminase: multiple forms of the enzyme from pig heart cytosol. FEBS Lett (1973) 0.79
[Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications]. Mol Biol (Mosk) (1998) 0.78
Location of exposed and buried cysteine residues in the polypeptide chain of aspartate aminotransferase. FEBS Lett (1973) 0.78
[Association of polymorphic markers Arg72Pro of TP53 and T309g of MDM2 genes with non small cell lung cancer in Russians of Moscow region]. Mol Biol (Mosk) (2015) 0.78
[Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications]. Mol Biol (Mosk) (1997) 0.78
[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow]. Mol Biol (Mosk) (2008) 0.78
Presence of HIV DNA in neutrophils: relationship to their functional activity. AIDS (1992) 0.78
[Methylation profile of group of miRNA genes in clear cell renal cell carcinoma; involvement in cancer progression]. Genetika (2013) 0.78
Methylation of miRNA genes and oncogenesis. Biochemistry (Mosc) (2015) 0.78
Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis. Biochemistry (Mosc) (2016) 0.77
Frequency analysis of HLA-DQA1 and HLA-DQB1 gene alleles and susceptibility to type 1 diabetes mellitus in Russian patients. Acta Diabetol (1994) 0.77
[Association of the chromosomal region 2q35 with type 1 diabetes mellitus in the Russian patients from Moscow]. Genetika (2008) 0.77
[Association of gene TP53 polymorphic marker Pro72Arg with clinical characteristics of chronic glomerulonephritis]. Ter Arkh (2011) 0.77
[Polymorphic markers Val762Ala and Leu54Phe of the ADPRT1 gene associated with chronic glomerulonephritis in Russian patients from the city of Moscow]. Genetika (2007) 0.77
[Gene IL6 G(-174)C and gene IL10 G(-1082)A polymorphisms are associated with unfavourable outcomes in patients with acute coronary syndrome]. Mol Biol (Mosk) (2010) 0.77
[Restriction and electron microscopic analyses of deletion derivatives thermosensitive with respect to maintaining plasmid pEG1]. Genetika (1980) 0.77
Genetic determinants of Graves disease. Mol Genet Metab (2000) 0.77
[Association of the C1858T polymorphism of the PTPN22 gene with type 1 diabetes]. Mol Biol (Mosk) (2010) 0.77
[Association of a polymorphic marker Trp719Arg of KIF6 gene with effects of atorvastatin and simvastatin in patients with early ischemic heart disease]. Kardiologiia (2011) 0.77
[Elimination of introns from the interleukin 1 beta genome by DNA amplification and expression of interleukin 1 beta in Escherichia coli]. Mol Biol (Mosk) (1992) 0.77
Two-step modification of aspartate aminotransferase with 1,5-difluoro-2,4-dinitrobenzene. Cross-link localization. Biochim Biophys Acta (1978) 0.77
[Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders]. Zh Nevrol Psikhiatr Im S S Korsakova (1998) 0.76
[Clinical and prognostic significance of genetic markers of ApoE gene in traumatic brain injury]. Zh Vopr Neirokhir Im N N Burdenko (2011) 0.76
[Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age]. Kardiologiia (2005) 0.76
[Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region]. Mol Biol (Mosk) (2006) 0.76
[Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis]. Ter Arkh (1999) 0.76
[Novel miRNA genes methylated in lung tumors]. Genetika (2013) 0.76
[Association of the polymorphisms of the ERBB3 and SH2B3 genes with type 1 diabetes]. Mol Biol (Mosk) (2010) 0.76
[Polymorphism of vascular angiotensin II receptor gene and cardiovascular disorders]. Ter Arkh (2000) 0.76
The structure of the expressible VH gene from a hybridoma producing monoclonal antibodies against porcine transferrin. Nucleic Acids Res (1989) 0.75
[Association of polymorphic marker A1/A2 of gene ITGB3 with coronary artery disease and myocardial infarction]. Genetika (2004) 0.75
[Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma]. Mol Biol (Mosk) (2009) 0.75
[Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes]. Mol Biol (Mosk) (2015) 0.75
[Design of recombinant plasmids for effective Zymomonas mobilis pyruvate decarboxylase (pdk) gene expression in Bacillus subtilis cells]. Mol Biol (Mosk) (1994) 0.75
Application of spin-labeled vitamin B6 analogues for the study of aspartate aminotransferase. FEBS Lett (1974) 0.75
[Structural organization of the non-transcribed spacer of the rat ribosomal repeated sequence]. Mol Biol (Mosk) (1985) 0.75
Spin-labeled vitamin B6 derivatives: synthesis and interaction with aspartate aminotransferase. Methods Enzymol (1979) 0.75
[Analysis of allelic loss in the area of the short arm of chromosome 3 in carcinomas of the kidney, uterus and ovaries using tri- and tetrameric markers]. Mol Biol (Mosk) (1998) 0.75
[Analysis of the distribution of microsatellites of seven motiffs within a cosmid of an ordered human chromosome 13 library]. Mol Biol (Mosk) (1996) 0.75
[Tetranucleotide markers based on a cosmid from the ordered clone library of human chromosome 13]. Mol Biol (Mosk) (1997) 0.75
[Methylation in the Regulation of the Expression of Chromosome 3 and microRNA Genes in Clear-Cell Renal Cell Carcinomas]. Genetika (2015) 0.75
[Primary structure of cytoplasmic aspartate aminotransferase from pig heart muscle. Amino acid sequence of peptides from cyanogen bromide hydrolysate]. Biokhimiia (1976) 0.75
Selective modification of tyrosine and cysteine residues in aspartate aminotransferase from pig heart cytosol. Biochem Biophys Res Commun (1973) 0.75
[Evaluation of the activity of cytokine genes--a new diagnostic test in immunology]. Vestn Akad Med Nauk SSSR (1991) 0.75
[Design of the human GM-CSF gene using the polymerase chain reaction and its expression in Pseudomonas putida cells]. Mol Biol (Mosk) (1995) 0.75
[Search for expansion of CAG-repeats in DNA sequences expressed in the brain of humans with psychiatric and neurological diseases]. Vopr Med Khim (1997) 0.75